NOT KNOWN FACTUAL STATEMENTS ABOUT CHECK A COPYRIGHT WALLET

In spite of reaching a whole response with best induction therapy, small residual illness normally persists, necessitating consolidation therapy to mitigate the risk of relapse by eradicating residual ailment. In sufferers who've acquired 7+3 induction therapy, consolidation therapy is initiated with significant-dose cytarabine, also known as HiDA